News & Insights
Sort By
Insights 132 Results
Insights
|April 23, 2026
Client Insight: SEC Order Permits Shorter Tender Offer Timelines
A recent order by the Securities and Exchange Commission reduced the minimum initial offering period for certain tender offers for equity securities from 20 business days to 10 business days, easing one of the most cited inconveniences in conducting a tender offer. The shorter timeline may only be used for tender offers for private company stock when the offer is made by the issuer of the securities (i.e., the company itself) or a wholly-owned subsidiary of the issuer, which may increase the appeal of structuring large liquidity programs as company-led (rather than third party-led). This timing advantage will likely push more private company liquidity events into issuer-structured programs.
Insights
|March 23, 2026
Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure’s article, "The Legal Playbook for Building a Biotech Company, From Formation to Financing," which discusses how a biotech company’s legal needs shift quickly as it grows and explores how founders can build the right legal foundation, avoid common missteps, and bring in the right counsel at the right time.
Insights
|March 16, 2026
Client Insight: Quarterly Employment Law Update — Winter 2026
This update highlights key legislative and regulatory changes taking effect this winter, noteworthy lawsuits, and recent updates to Gunderson Dettmer’s Contract Generator, with links to deeper-dive resources where relevant
Events 23 Results
Events
|January 27, 2026
Tim Ehrlich, Chair of Gunderson Dettmer’s Life Sciences practice and host of the “What’s Next in Biotech” series, sits down with Hogan Lovells Partner and former senior FDA official Elizabeth Jungman for a candid conversation about where biotech regulatory pathways stand today and where they are headed next.
Events
|January 22, 2026
Employment & Labor Partner Max Perlman is the chair of MCLE’s upcoming seminar “Employment Law for Business Lawyers & In-House Counsel” and will be presenting on developments in noncompete law and navigating the current Administration’s impact on labor and employment law
Events
|December 11, 2025
Katten and Gunderson Dettmer discusses the SEC’s recent policy statement on mandatory securities arbitration and whether it represents a meaningful shift for companies and their investors
Client News 127 Results
Client News
|May 14, 2026
Nectar Social Raises $30 Million Series A
Nectar Social announces its $30 million Series A financing led by Menlo Ventures with participation from True Ventures, Google Ventures, and Gwyneth Paltrow’s Kinship Ventures.
Client News
|May 12, 2026
Thrive Capital Leads Isomorphic Labs’ $2.1 Billion Series B
Thrive Capital led the $2.1 billion Series B financing of Isomorphic Labs, an AI-first drug design and development company.
Client News
|May 3, 2026
Dalus Capital Invests in Alkemio $2 Million Financing
Gunderson Dettmer represented client Dalus Capital in the $2 million pre-seed financing of Alkemio, a Buenos Aires-based company focused on developing a deep-tech modular low-emission refining system for on-site production of high-purity rare earth element oxides.
Firm News 46 Results
Firm News
|February 1, 2026
Gunderson Dettmer Commemorates 2026 Black History Month
Gunderson Dettmer commemorates Black History Month in February 2026 with a series of events across its US offices, access to resources, and a tribute to this month’s theme, "A Century of Black History Commemorations."
Firm News
|January 12, 2026
Richard Chang Recognized Again in China Business Law Journal’s The A-List 2025-26: Growth Drivers
Richard Chang, Corporate Partner and Head of Gunderson Dettmer’s Beijing office, has once again been named to China Business Law Journal’s A-List as China’s 2025-26 Growth Drivers Elite International Lawyers.
Blog Posts 31 Results
Public Ventures
|May 6, 2026
SEC Proposes Optional Semiannual Financial Reporting Framework for Public Companies
“Today’s proposal is just the first step of the larger, comprehensive effort to review and reshape the current SEC rules governing public companies with respect to their ongoing reporting obligations and their ability to raise capital in the public markets. Over the next few months, I expect that the Commission will be considering a series of proposals that, if adopted, will not only redefine what it means to be a public company, but will make being public attractive again.”
Public Ventures
|April 23, 2026
On April 16, 2026, the Office of Mergers and Acquisitions of the SEC’s Division of Corporation Finance (Division) issued an exemptive order shortening the standard 20-business-day minimum initial offering period to 10 business days for qualifying issuer and third-party fixed-price, all-cash tender offers for equity securities of both reporting and non-reporting companies. The relief is subject to specified conditions, including disclosure requirements and advance notice periods for material changes.
Public Ventures
|February 17, 2026
“Under my leadership, there is an open-door policy in the Division. I invite companies, investors, and other market participants to tell us what’s working and what’s not, and where there are issues, please propose a solution. The Division is ready to usher in a new day for public companies and their investors. We need your ideas, suggestions, comments, and data to get there. Help us help you!”